Reddy V S, O'Neill J A, Holcomb G W, Neblett W W, Pietsch J B, Morgan W M, Goldstein R E
Department of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, 37232-2577, USA.
Am Surg. 2000 Dec;66(12):1085-91; discussion 1092.
Our objective was to analyze the presentation, diagnostic localization, operative management, histology, and long-term outcome of a single center's experience with pheochromocytomas in children. A chart review was done to identify all operatively managed pheochromocytomas in patients age 18 years or younger. Open and laparoscopic cases were included. We reviewed the presentation, diagnostic imaging, localization, operative management, pathology, and postoperative outcome of these patients. Clinic visits, contact with the tumor registry, and telephone interviews were used for follow-up. From 1973 through 1999, there were 11 children (four males and seven females) with 14 pheochromocytomas. Two (18.2%) patients had bilateral adrenal lesions and one patient had both adrenal and extra-adrenal tumors. Six (54.5%) patients had extra-adrenal lesions. The average age at operation was 14.7 years (range 9-18 years). Nine (82%) patients had significant hypertension at presentation. CT was used to localize the tumor in eight patients and urine catecholamine levels were used to confirm the diagnosis. Two of the cases were associated with inherited syndromes (multiple endocrine neoplasia 2A and von Hippel-Lindau). Ten patients underwent an open operation and one patient had a laparoscopic resection. The average patient follow-up was 9.2 years (range 9 months to 25 years). There were no operative complications and all patients were alive and well at the time of last follow-up. Three patients (27.2%) had tumors with microscopic malignant features. No tumors recurred or had evidence for metastatic spread. We conclude that peak incidence of pheochromocytomas in children is in early adolescence. Resection can be carried out safely with minimal morbidity and mortality. Current best management of this entity includes establishment of a biochemical diagnosis, adequate preoperative blockade, appropriate imaging, and an individualized operative approach based on tumor location and size.
我们的目标是分析单一中心儿童嗜铬细胞瘤的临床表现、诊断定位、手术治疗、组织学及长期预后。通过查阅病历,确定18岁及以下接受手术治疗的所有嗜铬细胞瘤患者。纳入开放手术和腹腔镜手术病例。我们回顾了这些患者的临床表现、诊断性影像学检查、定位、手术治疗、病理及术后结果。通过门诊随访、与肿瘤登记处联系及电话访谈进行随访。1973年至1999年,有11名儿童(4名男性和7名女性)患有14个嗜铬细胞瘤。2名(18.2%)患者有双侧肾上腺病变,1名患者既有肾上腺肿瘤又有肾上腺外肿瘤。6名(54.5%)患者有肾上腺外病变。手术平均年龄为14.7岁(范围9 - 18岁)。9名(82%)患者就诊时患有重度高血压。8名患者通过CT定位肿瘤,尿儿茶酚胺水平用于确诊。其中2例与遗传性综合征相关(多发性内分泌腺瘤2A和冯希佩尔 - 林道病)。10名患者接受了开放手术,1名患者接受了腹腔镜切除术。患者平均随访时间为9.2年(范围9个月至25年)。无手术并发症,最后一次随访时所有患者均存活且状况良好。3名(27.2%)患者的肿瘤具有微小恶性特征。无肿瘤复发或转移证据。我们得出结论,儿童嗜铬细胞瘤的发病高峰在青春期早期。切除手术可安全进行,发病率和死亡率极低。目前对该疾病的最佳治疗包括建立生化诊断、充分的术前阻滞、适当的影像学检查以及基于肿瘤位置和大小的个体化手术方法。